ArticleScientific reports2023

Repurposing of neprilysin inhibitor 'sacubitrilat' as an anti-cancer drug by modulating epigenetic and apoptotic regulators.

Navanath Kumbhar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.